Serum REG1A protein is a biomarker for diagnosis and progression prediction of pancreatitis
Serum REG1A is a promising biomarker for diagnosing pancreatitis, and predicting both AP severity and CP progression. These findings underscore the potential role of REG1A in the diagnosis and management of pancreatitis.
Authors
- Zhiqin Xie (ORCID: https://orcid.org/0000-0002-3011-5031)
- Xin Geng (ORCID: https://orcid.org/0000-0003-0604-5392)
- De-Jian Bian
- Wenbin Zou
- Qiwen Wang (ORCID: https://orcid.org/0000-0002-4255-3960)
- Zhuan Liao (ORCID: https://orcid.org/0000-0001-7932-5403)
- Bowen Li (ORCID: https://orcid.org/0009-0009-9679-3714)
- Yi Xu (ORCID: https://orcid.org/0000-0002-5361-1812)
- Hao Zheng (ORCID: https://orcid.org/0000-0003-4378-6560)
Institutions
- Central South University (CN)
- Hunan Normal University (CN)
- Second Military Medical University (CN)
- Naval University of Engineering (CN)
- Changhai Hospital (CN)
- Qinhuangdao Science and Technology Bureau (CN)
- Zhuzhou Central Hospital (CN)
- Hunan Provincial People's Hospital (CN)
Publication Details
- Journal
- BMC Gastroenterology
- Published
- 2025-11-29
- DOI
- https://doi.org/10.1186/s12876-025-04477-8
- Primary Topic
- Pancreatitis Pathology and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00